# Bolt Biotherapeutics, Inc.: Form DEF 14A, filed Apr 28, 2026

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: DEF 14A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 16:05 ET
- Period: 2026-04-27
- Accession: 0001193125-26-186923
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000119312526186923/bolt-20260424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000119312526186923/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000119312526186923/bolt-20260424.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-186923. Last ingested by Listed: Nov 13, 2026, 15:45 ET. No prices; not investment advice.
